Appco Pharma
4 federal recalls on file, showing the 3 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Appco Pharma and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-04-08FDA-DrugClass IIStop using recalled prazosin hydrochloride capsules
Appco Pharma LLC is recalling specific lots of prazosin hydrochloride 5mg capsules because they contain higher-than-acceptable levels of a nitrosamine impurity (N-nitroso-prazosin). Nitrosamines are chemical contaminants that may increase health risks with long-term exposure. This is a manufacturing quality issue, not a safety defect in the drug itself.
- 2026-04-08FDA-DrugClass IIStop using Appco Pharma prazosin capsules
Appco Pharma LLC is recalling specific lots of prazosin hydrochloride 2mg capsules because they contain higher-than-allowed levels of a nitrosamine impurity called N-nitroso-prazosin. Nitrosamines are chemicals that may increase cancer risk with long-term exposure. No injuries have been reported so far.
- 2026-04-08FDA-DrugClass IIStop taking recalled prazosin capsules
Appco Pharma LLC is recalling prazosin hydrochloride 1mg capsules (100-count bottles) because they may contain higher-than-acceptable levels of a nitrosamine impurity. This impurity was detected during manufacturing quality checks. The recall affects specific lot numbers distributed nationwide.
Get notified about new Appco Pharma recalls
Free weekly digest. We email when a new federal recall affects Appco Pharma or anything else in your household.
Get the Sunday Brief